| Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors |
SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of healthcare industry veteran Kevin O'Boyle to its Board of Directors and as chair of its Audit Committee. With Mr. O'Boyle's appointment, the company also announced that Dale E. Jones has stepped down from the Board. |
globenewswire.com |
2025-05-14 13:00:00 |
Czytaj oryginał (ang.) |
| Outset Medical to Present at RBC Global Healthcare Conference |
SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 20, 2025, at 10:30 a.m. Eastern time. |
globenewswire.com |
2025-05-09 13:00:00 |
Czytaj oryginał (ang.) |
| Outset Medical, Inc. (OM) Q1 2025 Earnings Call Transcript |
Outset Medical, Inc. (OM) Q1 2025 Earnings Call Transcript |
seekingalpha.com |
2025-05-08 01:30:45 |
Czytaj oryginał (ang.) |
| Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates |
Outset Medical, Inc. (OM) came out with a quarterly loss of $3.24 per share versus the Zacks Consensus Estimate of a loss of $0.97. This compares to loss of $8.55 per share a year ago. |
zacks.com |
2025-05-07 22:30:44 |
Czytaj oryginał (ang.) |
| Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined |
SAN JOSE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the first quarter ended March 31, 2025. |
globenewswire.com |
2025-05-07 20:02:00 |
Czytaj oryginał (ang.) |
| OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm |
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outset Medical, Inc. (NASDAQ:OM) on behalf of long-term stockholders following a class action complaint that was filed against Outset Medical on August 29, 2024 with a Class Period from August 1, 2022 to August 7, 2024. Our investigation concerns whether the board of directors of Outset Medical have breached their fiduciary duties to the company. |
globenewswire.com |
2025-04-30 01:00:00 |
Czytaj oryginał (ang.) |
| Does Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect? |
The consensus price target hints at a 71.7% upside potential for Outset Medical (OM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
zacks.com |
2025-04-21 14:55:40 |
Czytaj oryginał (ang.) |
| Wall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should Know |
The consensus price target hints at an 188.6% upside potential for Outset Medical (OM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
zacks.com |
2025-04-02 15:00:48 |
Czytaj oryginał (ang.) |
| Outset Medical Announces One-for-Fifteen Reverse Stock Split |
SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced a one-for-fifteen reverse stock split (the “Reverse Stock Split”) of the Company's common stock, par value $0.001, which will become effective at 12:01 a.m. Eastern Time on Thursday, March 20, 2025. The Company's common stock will continue to trade under Outset's existing trading symbol, OM, on the Nasdaq Global Select Market (“Nasdaq”) on a split-adjusted basis when the market opens on Thursday, March 20, 2025, with the new CUSIP number 690145206. |
globenewswire.com |
2025-03-18 10:30:00 |
Czytaj oryginał (ang.) |
| Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now |
Outset Medical (OM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. |
zacks.com |
2025-02-26 13:01:31 |
Czytaj oryginał (ang.) |
| 3 Cryptocurrencies That Could Be Better Buys Than Bitcoin Right Now |
In 2025, Bitcoin (BTC -1.18%) has over-promised and under-delivered. After reaching $100,000 in December, Bitcoin looked like a no-brainer option to soar in value this year. |
fool.com |
2025-02-26 10:30:00 |
Czytaj oryginał (ang.) |
| Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference |
SAN JOSE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 45th annual TD Cowen Health Care conference on Tuesday, March 4, 2025, at 2:30 p.m. |
globenewswire.com |
2025-02-24 18:03:00 |
Czytaj oryginał (ang.) |
| Outset Medical, Inc. (OM) Q4 2024 Earnings Call Transcript |
Outset Medical, Inc. (NASDAQ:OM ) Q4 2024 Earnings Conference Call February 19, 2025 5:00 PM ET Company Participants Jim Mazzola - Head of Investor Relations Leslie Trigg - Chair and CEO Nabeel Ahmed - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Shagun Singh - RBC Capital Markets Suraj Kalia - Oppenheimer Operator Good day, and thank you for standing by. Welcome to the Outset Medical Fourth Quarter 2024 Earnings Conference Call. |
seekingalpha.com |
2025-02-19 22:54:40 |
Czytaj oryginał (ang.) |
| Outset Medical: Profitability Path Brightens |
Outset Medical (OM 3.52%), the innovator behind the Tablo Hemodialysis System, reported fourth-quarter earnings on Wednesday, Feb. 19, that topped analysts' consensus expectations on top and bottom lines. Fourth-quarter revenue of $29.5 million exceeded the forecasted $28 million, indicating resilience in revenue growth despite market hurdles. |
fool.com |
2025-02-19 20:22:05 |
Czytaj oryginał (ang.) |
| Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates |
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.59 per share a year ago. |
zacks.com |
2025-02-19 20:15:33 |
Czytaj oryginał (ang.) |
| Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results |
SAN JOSE, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2024. |
globenewswire.com |
2025-02-19 18:03:00 |
Czytaj oryginał (ang.) |
| Outset Medical Announces Resolution of Warning Letter |
SAN JOSE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced it has been notified by the Food and Drug Administration that all issues cited in a Warning Letter the company received in July of 2023 have been addressed. |
globenewswire.com |
2025-02-13 18:35:00 |
Czytaj oryginał (ang.) |
| Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release |
Outset Medical (OM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-02-12 13:07:00 |
Czytaj oryginał (ang.) |
| Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm |
NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Outset Medical, Inc. (NASDAQ: OM) breached their fiduciary duties to shareholders. |
globenewswire.com |
2025-02-06 19:52:00 |
Czytaj oryginał (ang.) |
| Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025 |
SAN JOSE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2024 after the close of trading on Wednesday, February 19, 2025. |
globenewswire.com |
2025-02-03 11:00:00 |
Czytaj oryginał (ang.) |
| Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors |
Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt |
globenewswire.com |
2025-01-06 10:30:00 |
Czytaj oryginał (ang.) |
| OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm |
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outset Medical, Inc. (NASDAQ: OM) on behalf of long-term stockholders following a class action complaint that was filed against Outset Medical on August 29, 2024 with a Class Period from August 1, 2022 to August 7, 2024. Our investigation concerns whether the board of directors of Outset Medical have breached their fiduciary duties to the company. |
globenewswire.com |
2024-12-03 23:00:00 |
Czytaj oryginał (ang.) |
| Outset Medical to Present at the 2024 Stifel Healthcare Conference |
SAN JOSE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 2024 Stifel Healthcare conference on Tuesday, November 19, 2024, at 10:20 a.m. Eastern time. |
globenewswire.com |
2024-11-15 11:00:00 |
Czytaj oryginał (ang.) |
| Outset Medical Inc. (OM) Q3 2024 Earnings Call Transcript |
Outset Medical Inc. (NASDAQ:OM ) Q3 2024 Results Conference Call November 6, 2024 5:00 PM ET Company Participants James Mazzola - Head of Investor Relations Leslie Trigg - President, CEO & Chairman Nabeel Ahmed - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Avi Kohn RBC - Capital Markets Suraj Kalia - Oppenheimer & Co Marie Thibault - BTIG Josh Jennings - TD Cowen Operator Good day, and thank you for standing by. Welcome to the 2024 Third Quarter Outset Medical Conference Call. |
seekingalpha.com |
2024-11-07 11:28:07 |
Czytaj oryginał (ang.) |
| Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates |
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.71 per share a year ago. |
zacks.com |
2024-11-06 20:26:15 |
Czytaj oryginał (ang.) |
| Outset Medical Reports Third Quarter 2024 Financial Results |
SAN JOSE, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2024. |
globenewswire.com |
2024-11-06 18:02:00 |
Czytaj oryginał (ang.) |
| Contact Levi & Korsinsky by October 28, 2024 Deadline to Join Class Action Against Outset Medical, Inc.(OM) |
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109746&wire=1 or contact Joseph E. Levi, Esq. |
accesswire.com |
2024-10-28 18:30:00 |
Czytaj oryginał (ang.) |
| Investors in Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM |
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109727&wire=1 or contact Joseph E. Levi, Esq. |
accesswire.com |
2024-10-28 14:45:00 |
Czytaj oryginał (ang.) |
| Levi & Korsinsky Notifies Outset Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - OM |
NEW YORK, NY / ACCESSWIRE / October 28, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/outset-medical-lawsuit-submission-form?prid=109608&wire=1 or contact Joseph E. Levi, Esq. |
accesswire.com |
2024-10-28 11:00:00 |
Czytaj oryginał (ang.) |